{"name":"Aspen Neuroscience","slug":"aspen-neuroscience","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiqgFBVV95cUxQR3dKZWhsUktCWmRISmJKdC1sS2tyVzZzaTNvZHR5SGhDMTVyOE1paDM4UXNtRjVOazMzVGtwVEx1SW96Q205Y3BsM3AtRkhLTFhINTNuZkFrTVlBZ2xJS0wtZ2hQdkZKZ0lmQ1lMLVZrWUVuUWwwbktTVXQzVHRxc1ZkcDk1RnF4c3Y3NXVmRU1aVUE3VDVSMFlJWk5jLU5FODM1VTMyZ2hfUQ?oc=5","date":"2026-03-18","type":"trial","source":"Fierce Biotech","summary":"Aspen's 1-year data for Parkinson's cell therapy plant seeds for phase 3 trial - Fierce Biotech","headline":"Aspen's 1-year data for Parkinson's cell therapy plant seeds for phase 3 trial","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilwFBVV95cUxONTF0QXVfOV80dUpzSVNpbjNDYkV0OUhaenB0clEtM3I2RHBTZXVobTEzRWVCeWtESk9LRDVNNnByTnFBSnBONFZDNFhCcG9CV0drYVcwUDhJZ1RidWlGeTBnb3pLWmFOZ2ZqRWNmQVNtT3puOERGV3gwUkdqOHozV25mTUJienpqZkZoS2ZfaDhyMEZlTUFZ?oc=5","date":"2026-01-07","type":"pipeline","source":"Fierce Pharma","summary":"Viking enlists commercial chief to battle obesity giants, while Aspen names CCO to prep for Parkinson's launch - Fierce Pharma","headline":"Viking enlists commercial chief to battle obesity giants, while Aspen names CCO to prep for Parkinson's launch","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2026-01-07","type":"pipeline","source":"PR Newswire","summary":"Aspen Neuroscience Appoints Chief Commercial Officer Lisa Johnson-Pratt, M.D. and Welcomes Revati Shreeniwas, M.D., FCCP as Chief Medical Officer to Accelerate Late‑Stage Development and Commercial Re","headline":"Aspen Neuroscience Appoints Chief Commercial Officer Lisa Johnson-Pratt, M.D. and Welcomes Revati Shreeniwas, M.D., FCCP","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilwFBVV95cUxNQWliVkVXOGF5NWlMUmtXeVFHX0RKQ21hUEtKd3JEdkttNFNjeFZydWpLQkw5Q2VuMU5VUkRzVy0zY21FaE1XR0tPNWtzdjdkZVZTNm9TS2xSTUVwM1A5aXc0N09fZjlQY0ZDU1plc09kQlVIcVdNeWRUVE9FNHFCYnF6Qm12Nng4VnB4ek1WQmtLQmJNQlhZ?oc=5","date":"2025-11-24","type":"pipeline","source":"Longevity.Technology","summary":"Aspen Neuro lands $115m to advance Parkinson’s cell therapy - Longevity.Technology","headline":"Aspen Neuro lands $115m to advance Parkinson’s cell therapy","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMifEFVX3lxTE1rR19yNFpsSWhYVkRsX2Q1eGlYNkQ1b28wRWFrYjE3U29tNEROWTBMSjZRczY1ck01aGFlajdyZnV2akJoanExd1RhcGg3Y3ExOFdobmtRdXhZdGc4REdpbkFrTVVyOF9LRzFNV1BRbkZ3a2l0Q2RIbWtRYWo?oc=5","date":"2025-11-21","type":"pipeline","source":"Pharmaceutical Technology","summary":"Aspen closes $115m in Series C to advance Parkinson’s cell therapy - Pharmaceutical Technology","headline":"Aspen closes $115m in Series C to advance Parkinson’s cell therapy","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi9wFBVV95cUxQRjZDRHBXYk41SFQ0UTVkclFtTVVJWEJ0SG4xdmVPOVZpamcxRzVvWnAySTJfS01xNV9wWlkyaHBqdlNlVEQyaDRhbm9KcklrWE91WVZYQ0RUV1g1MjdGSVdDRHRsUU5QejZWd1BxRXlBNTlMMENoemJQdWxFSHVIX3I1Mm1rbjNKdElncmo4VUlpcGdrcDVPSjBGM0ZfQzBXN3A2ZXdabGpySUlYOVdZWHRqd0FacnVhTG4xMkZTQlloRmJWSnhmcVA3NWhNY2xHaGdHa1hfQ2diQS0za0JjdFFaenBVZmd0WHN3bEFQMEhGekx0X0Fv?oc=5","date":"2025-11-20","type":"pipeline","source":"PR Newswire","summary":"Aspen Neuroscience Announces $115 Million Series C Financing to Accelerate Personalized Cell Therapy Programs - PR Newswire","headline":"Aspen Neuroscience Announces $115 Million Series C Financing to Accelerate Personalized Cell Therapy Programs","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirAFBVV95cUxOdHlSSDEySUw1RFdBM0t5Q0V2amdQNjVMUG0tYXFPczVYVjJXcDRKTjlKSHhEeWt6clFkTGlDRkxFRTRqNGhvSUJraWE1TVZYRTBPYTAtX3FjY21Gb0x0NW5xeEFJVzg4ZTRwWkU2Z3pocVBrVy1tZ2x3UGFNbHBCMkJId3NxeWtlOEJDenZlbEZLNzRsU1M3U0thM2RDREJPaFJRRHJGZUdLOEFC?oc=5","date":"2025-11-20","type":"trial","source":"Fierce Biotech","summary":"Aspen enriches Parkinson's cell therapy trial with Kite-backed $115M series C - Fierce Biotech","headline":"Aspen enriches Parkinson's cell therapy trial with Kite-backed $115M series C","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMioAFBVV95cUxPdVJjSHp5LUVGdFVwbHRwOThuVEd1alA5Q1hnU2JkX3owcjlYSkYwdFhvVXFjMTJTOVRMT3hDNnB1NWwzVHRpVXI3eW41cU56TnBDVG1fcWtCSFlNQ3JVREF3Zjk4TjFhWGdMQW9TcGx5a3RLaWl6MHRJbll6YnM2NVdpeE8tc1JacWVFWUxJSERzSjJHR21HdXJBbHEwX3ZK?oc=5","date":"2025-11-20","type":"pipeline","source":"BioPharma Dive","summary":"Aspen raises $115M for a Parkinson’s stem cell treatment - BioPharma Dive","headline":"Aspen raises $115M for a Parkinson’s stem cell treatment","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiU0FVX3lxTFBidm5TcGxtR3F1cUxDdFpmTnQxUEtuMGpKVXdzbGJDWXExa0JaRW1YOW9jczBQZzIyZzVtaXdwekNBaWZjOEluWGIyLVpkMlVCcTZn?oc=5","date":"2025-11-20","type":"pipeline","source":"FirstWord Pharma","summary":"Progress on Aspen's personalised cell therapy for Parkinson's prompts $115M raise - FirstWord Pharma","headline":"Progress on Aspen's personalised cell therapy for Parkinson's prompts $115M raise","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirgFBVV95cUxPV19GdktlWnRRWkZMMjN3bE1VcjVtYnNoYzNDN0xxYm15dklkZE1UcWYyUFl1RDBxODUza2xQNTJ5OGt5Q18xTFFVVGEyRENXbWFUdUpJQlpMeGhZQk1LWk54MVpsQWpjbkRwMmxsdWM2N3UzeWlGcmN3MjFTeFNSOE16azh1ZU1yMUVyNm9rLVZjT1h3eVQzcVBNb0xRMm12SkNSUm15X0s2OFV4RFE?oc=5","date":"2025-11-05","type":"pipeline","source":"San Diego Business Journal","summary":"Prebys Ventures Invests in 5 Life Sciences, Health Care Startups - San Diego Business Journal","headline":"Prebys Ventures Invests in 5 Life Sciences, Health Care Startups","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivAFBVV95cUxPNlhZaTgzTGtxUmFCUUhERlE1eTI2c2VaVEUwMUhGbUxONlRKUTdiZzdGbm94d2RiRWdidndQQ05DcHFYU05qYWxJQkpOMTJ0aXk4MGcxNDJQNnllNmFaOXlQMHdiNGoxcF82WXhIc0kyeURHbkk4eGVfanFnMXRYcGJaNER6ZUJSd1FLcFk5NVdRZDVyUEJWODd5NWlCM2V5Q2owYjhhTUZmTjkzWHRNZTBMekpnbU1RcHN6bQ?oc=5","date":"2025-10-24","type":"pipeline","source":"Times of San Diego","summary":"Prebys Ventures invests $5 million in five San Diego healthcare startups - Times of San Diego","headline":"Prebys Ventures invests $5 million in five San Diego healthcare startups","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixwFBVV95cUxORHBEeUNOZGVJeG9uakx5aXd2eVB6QTV2NzhsbU1OV3VlQTlOd0tNLVJvZlg4djYwWW52MU9CSzNKZ0hqQldkVEZpT1JfMnQ2alphY21GZUt1cG5jSmwxSExCNHF0N2lNMGZGbl9QSEVpUFFxMENSLWxuOXl2cmJiakd3VHRKNDN5emtaRE5aTDJSLWJ6YlI2OS1nVVJSaDhXLURUZXpwUmJrT0VfTW1yNlA1aFk4a2ZURG1GSk1wbFBtM3JlQnpF?oc=5","date":"2024-10-02","type":"trial","source":"Fierce Pharma","summary":"Aspen Neuroscience, underway with Parkinson's cell therapy trial, bolsters manufacturing with new San Diego facility - Fierce Pharma","headline":"Aspen Neuroscience, underway with Parkinson's cell therapy trial, bolsters manufacturing with new San Diego facility","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}